Citation Impact
Citing Papers
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome
1992
Abdominal obesity and metabolic syndrome
2006 StandoutNature
The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease
2006
Sjögren's syndrome
2005 Standout
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double‐blind, placebo‐controlled trial
2007
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
A simple technique for quantitation of low levels of DNA damage in individual cells
1988 Standout
Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
1997
Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets
1998
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Bariatric Surgery
2004 Standout
The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization
1999 Standout
Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia
1991
Trans Fatty Acids and Cardiovascular Disease
2006 Standout
Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys.
1991
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Multiple sclerosis
2008 Standout
Lack of evidence for use of glatiramer acetate in multiple sclerosis
2004
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
Polycystic Ovary Syndrome
1995 Standout
The origin and application of experimental autoimmune encephalomyelitis
2007
Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)
1995
A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis
1994
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Diabetes and Atherosclerosis
2002 Standout
Dietarytrans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women
1994
A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
1991
Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance
1995
Polycystic Ovary Syndrome
2005 Standout
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
1998 Standout
Changes in Plasma Lipoprotein and Apolipoprotein Composition in Relation to OralVersusPercutaneous Administration of Estrogen Alone or in Cyclic Association with Utrogestan in Menopausal Women
1991
Multiple Sclerosis
2000 Standout
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
2008
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
1995 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Natural history of multiple sclerosis
1994
Treatment of multiple sclerosis
1994
Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects
2003
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
1990 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 Standout
Validation of the Framingham Coronary Heart Disease Prediction Scores
2001 Standout
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
1992 Standout
Vitamin C and cancer prevention: the epidemiologic evidence
1991
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
Multiple sclerosis
2002 Standout
Recent progress in the diagnosis and treatment of multiple sclerosis
1999
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
1994 StandoutScience
Mechanisms of action of glatiramer acetate in multiple sclerosis
2001
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1998 Standout
Markers of Inflammation and Cardiovascular Disease
2003 Standout
The Natural History of Multiple Sclerosis
1995
Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
1990
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
1992
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
1992 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Ascorbate is an outstanding antioxidant in human blood plasma.
1989 Standout
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis
1987
Prooxidant States and Tumor Promotion
1985 StandoutScience
Multiple Sclerosis
2018 Standout
Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction
1997
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Dietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men
2002
Elevated C-Reactive Protein
2001
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Sex Bias in Considering Coronary Bypass Surgery
1987
Normal oxidative damage to mitochondrial and nuclear DNA is extensive.
1988 Standout
Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis
1993 Science
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Epidemiology of uterine cervical cancer
1986
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
Rationale and strategies for chemoprevention of cancer in humans.
1987
Precipitation methods for quantification of lipoproteins
1986
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome
1995
Bilirubin Is an Antioxidant of Possible Physiological Importance
1987 StandoutScience
β-Carotene: an Unusual Type of Lipid Antioxidant
1984 StandoutScience
Race, Visceral Adipose Tissue, Plasma Lipids, and Lipoprotein Lipase Activity in Men and Women
2000
Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
1985
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing–remitting MS
2007
DNA glycosylase activities for thymine residues damaged by ring saturation, fragmentation, or ring contraction are functions of endonuclease III in Escherichia coli.
1984 StandoutNobel
Effect of the Novel Antiplatelet Agent Cilostazol on Plasma Lipoproteins in Patients With Intermittent Claudication
1998
Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG
1991 StandoutNature
Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
2002
Works of Susan Slagle being referenced
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
1982
Chemoprevention of cervix cancer: Phase I–II: A feasibility study involving the topical vaginal administration of retinyl acetate gel
1985
DIETARY VITAMIN C AND UTERINE CERVICAL DYSPLASIA
1981
A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis
1987
Nuclear scans: A clinical decision making tool that reduces the need for cardiac catheterization
1987
A placebo‐controlled, double‐blind, randomized, two‐center, pilot trial of Cop 1 in chronic progressive multiple sclerosis
1991